XML 21 R79.htm IDEA: XBRL DOCUMENT v2.4.0.6
Supplemental Guarantor Condensed Consolidating Financials - Schedule of Consolidating Statement of Cash Flows (Detail) (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Dec. 29, 2012
Dec. 24, 2011
OPERATING ACTIVITIES    
Net cash provided by (used in) operating activities $ 155,025 $ 111,731
INVESTING ACTIVITIES    
Payment of additional acquisition consideration (16,808) (9,784)
Proceeds from sale of business, net 1,488  
Proceeds from sale of intellectual property 60,000  
Purchase of property and equipment (11,233) (6,790)
Increase in equipment under customer usage agreements (11,214) (7,886)
Purchase of insurance contracts (4,000)  
Purchase of cost method investments (3,625) (150)
(Increase) decrease in other assets 1,144 9
Decrease in restricted cash   9
Net cash provided by (used in) investing activities 15,752 (24,601)
FINANCING ACTIVITIES    
Repayment of long-term debt (16,250)  
Payment of contingent consideration (3,408) (4,105)
Net proceeds from issuance of common stock pursuant to employee stock plans 12,777 1,627
Excess tax benefit related to equity awards 2,185 1,725
Payment of employee restricted stock minimum tax withholdings (7,885) (5,561)
Net cash used in financing activities (12,581) (6,314)
Effect of exchange rate changes on cash and cash equivalents (155) (66)
Net increase (decrease) in cash and cash equivalents 158,041 80,750
Cash and cash equivalents, beginning of period 560,430 712,332
Cash and cash equivalents, end of period 718,471 793,082
Parent Company [Member]
   
OPERATING ACTIVITIES    
Net cash provided by (used in) operating activities 112,839 108,796
INVESTING ACTIVITIES    
Payment of additional acquisition consideration (16,808) (9,784)
Purchase of property and equipment (2,887) (3,799)
Increase in equipment under customer usage agreements (286)  
Purchase of insurance contracts (4,000)  
Purchase of cost method investments (3,400)  
(Increase) decrease in other assets (1,967)  
Net cash provided by (used in) investing activities (29,348) (13,583)
FINANCING ACTIVITIES    
Repayment of long-term debt (16,250)  
Payment of contingent consideration (3,408) (4,105)
Net proceeds from issuance of common stock pursuant to employee stock plans 12,777 1,627
Excess tax benefit related to equity awards 2,185 1,725
Payment of employee restricted stock minimum tax withholdings (7,885) (5,561)
Net cash used in financing activities (12,581) (6,314)
Net increase (decrease) in cash and cash equivalents 70,910 88,899
Cash and cash equivalents, beginning of period 210,028 644,697
Cash and cash equivalents, end of period 280,938 733,596
Guarantor Subsidiaries [Member]
   
OPERATING ACTIVITIES    
Net cash provided by (used in) operating activities 30,075 7,101
INVESTING ACTIVITIES    
Proceeds from sale of intellectual property 60,000  
Purchase of property and equipment (6,037) (1,500)
Increase in equipment under customer usage agreements (7,172) (5,558)
Purchase of cost method investments (225) (150)
(Increase) decrease in other assets (478)  
Net cash provided by (used in) investing activities 46,088 (7,208)
FINANCING ACTIVITIES    
Effect of exchange rate changes on cash and cash equivalents (2,387) 107
Net increase (decrease) in cash and cash equivalents 73,776  
Cash and cash equivalents, beginning of period 269,416  
Cash and cash equivalents, end of period 343,192  
Non-Guarantor Subsidiaries [Member)
   
OPERATING ACTIVITIES    
Net cash provided by (used in) operating activities 12,111 (4,166)
INVESTING ACTIVITIES    
Proceeds from sale of business, net 1,488  
Purchase of property and equipment (2,309) (1,491)
Increase in equipment under customer usage agreements (3,756) (2,328)
(Increase) decrease in other assets 3,589  
Decrease in restricted cash   9
Net cash provided by (used in) investing activities (988) (3,810)
FINANCING ACTIVITIES    
Effect of exchange rate changes on cash and cash equivalents 2,232 (173)
Net increase (decrease) in cash and cash equivalents 13,355 (8,149)
Cash and cash equivalents, beginning of period 80,986 67,635
Cash and cash equivalents, end of period $ 94,341 $ 59,486